D. E. Shaw & Co., Inc. Surface Oncology, Inc. Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.45 - $9.09 $145,802 - $205,479	-22,605 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.25 - $13.82 $196,286 - $374,162	-27,074 Reduced 54.5%	22,605 $176,000
Q4 2020 Feb 16, 2021	BUY	$6.87 - $10.48 $341,294 - $520,635	49,679 New	49,679 $459,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.